Для информации: Согласно запросу от

Для информации:
Согласно запросу от Министерства здравоохранения в лице НДА, прошу принять следующую информацию.
1) Пфайзер подготовил сопроводительное письмо и заявления для регистрации на 2015-2016 годы на все продукты. Данные документы (копия и оригинал) были представлены в МЗ и НДА 5 июня 2015.
2) Сутент. Пфайзер предоставил письмо (копия и оригинал) с обоснованием разницы цены по сравнению с Британским формуляром и настоял на регистрации ранее поданной цены.
3) Превенар. Пфайзер дал разъяснения, что представленная цена (см.пункт 1) - для регистрации и будет использована как основа для розничной цены. Цена НИПа -конфиденциальная информация, которая не может быть опубликована.
4) ГЕП. Письмо к сожалению даже еще не направлено в Нью Йорк - ждем одобрения Лилии.

С уважением,
Дана

Results (English) 1:

For information: Pursuant to a request from the Ministry of health in the face of NDA, please accept the following information.1) Pfizer prepared cover letter and application for registration for 2015-2016 years for all products. These documents (original and one copy) were submitted to MOH and NDA June 5, 2015.2) Sutent. Pfizer provided a letter (copy and original) with the rationale for the difference of prices compared to the British form and insisted on the previously filed registration prices.Prevenar) 3. Pfizer explained that the price (see paragraph 1)-for registration and will be used as the basis for the retail price. Price Nipa-confidential information which may not be published. 4) GAP. The letter unfortunately not even directed in New York waiting for approval.With kind regards,Dana

Results (English) 2:

For information:
According to the request from the Ministry of Health represented by the NDA, please take the following information.
1) Pfizer has prepared a cover letter and application for registration for the years 2015-2016 for all products. These documents (original and copy) were presented in the Ministry of Health and the NDA 5 June 2015.
2) Sutent. Pfizer has provided a letter (original and copy) substantiating the price difference compared with the British form and has insisted on registration previously filed rates.
3) Prevenar. Pfizer clarified that the declared price (see paragraph 1) - for registration and will be used as the basis for the retail price. Price NPC -konfidentsialnaya information that may not be published.
4) GEO. Letter unfortunately not even sent to New York - waiting approval Lilies. Sincerely, Dana

Results (English) 3:

For information:
pursuant to a request from the Ministry of Health, through its NDA, I request you to take the following information.
(1) Pfizer has prepared a letter of transmittal and the application for registration in the 2015-2016 years, on all products. These documents (copy and the original) were presented in the MOH and NDA on 5 June 2015.
2) Сутент.Pfizer provided letter (a copy and the original) with a justification for price difference as compared with the British case and insisted on previously filed registration prices.
3) two serotypes. Pfizer provided clarification,The price submitted (see item 1) - for registration and will be used as the basis for the retail price. Price Nipa palms -confidential information, which may not be published.
(4) GEO.I unfortunately have not even sent in New York - we look forward to seeing the lilies.Lord with respect,
given